世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

フマル酸クエチアピンの世界市場規模、メーカー、サプライチェーン、販売チャネル、顧客、2025-2031年

フマル酸クエチアピンの世界市場規模、メーカー、サプライチェーン、販売チャネル、顧客、2025-2031年


Global Quetiapine Fumarate Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

2024年、フマル酸クエチアピンの世界市場規模は1億5,300万米ドルと推定され、予測期間2025-2031年のCAGRは-2.2%で、2031年には約1億3,100万米ドルに達すると予測されている。 フマル酸クエチアピンは、統合失調... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2025年4月9日 US$5,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

2024年、フマル酸クエチアピンの世界市場規模は1億5,300万米ドルと推定され、予測期間2025-2031年のCAGRは-2.2%で、2031年には約1億3,100万米ドルに達すると予測されている。
フマル酸クエチアピンは、統合失調症、双極性障害、うつ病などの精神疾患の治療に用いられる非定型抗精神病薬である。単独または他の精神科治療薬との併用で使用される。経口投与され、医師の監督の下、処方箋によってのみ入手可能です。

フマル酸クエチアピン市場は欧州が最大で、市場シェアは約92%。次いで中国が約2%のシェアを占めている。
主なプレーヤーは、アストラゼネカ、インタス、TAPI、アコード、ヘクサル、Dr.Reddy's、ルパン、太陽製薬、湖南東亭製薬、蘇州第4製薬工場、福安製薬、浙江スーポー製薬、浙江華海製薬などである。上位3社で約74%の市場シェアを占めている。

レポートの範囲
本レポートは、フマル酸クエチアピンの世界市場を量的・質的分析の両面から包括的に紹介し、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、フマル酸クエチアピンに関する十分な情報に基づいたビジネス上の意思決定を行えるようにすることを目的としています。
クエチアピンフマル酸塩の市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データと予測データを考慮し、販売量(MT)と収益(百万ドル)で提供します。本レポートでは、世界のフマル酸クエチアピン市場を包括的にセグメント化しています。製品タイプ別、用途別、プレイヤー別の地域別市場規模も掲載しています。
市場のより詳細な理解のために、競合状況、主要競合企業のプロフィール、それぞれの市場ランクを掲載しています。また、技術動向や新製品開発についても論じています。
本レポートは、フマル酸クエチアピンメーカー、新規参入企業、本市場における業界チェーン関連企業に対し、市場全体および企業別、タイプ別、用途別、地域別といった異なるセグメントにわたるサブセグメントの収益、販売量、平均価格に関する情報を提供するものです。

企業別
アストラゼネカ
インタス
タピ
アコード
ヘクサル
ドクター・レディーズ
ルパン
サン製薬
湖南東亭製薬
蘇州第4製薬工場
福安製薬
浙江スーポー製薬
浙江華海製薬
タイプ別セグメント
即時放出錠剤
徐放錠
用途別セグメント
成人
その他
地域別
北米
米国
カナダ
アジア太平洋
中国
日本
韓国
インド
東南アジア
オーストラリア
その他のアジア太平洋地域
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
その他のヨーロッパ
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他のMEA

各章の概要
第1章: レポートのスコープ、各市場セグメント(タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章 フマル酸クエチアピンの世界および地域レベルでの販売(消費)、収益。各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間を紹介しています。
第3章:フマル酸クエチアピンメーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。
第4章:主要メーカーのプロフィールを提供し、製品の説明と仕様、フマル酸クエチアピンの売上高、収益、価格、粗利益率、地域別、タイプ別、用途別の売上高、最近の開発など、市場の主要企業の基本状況を詳しく紹介する。
第5章:タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。
第6章:用途別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第7章:北米:タイプ別、用途別、国別、セグメント別の売上高、収益。
第8章:APAC:タイプ別、用途別、国別、セグメント別の売上高と収益。
第9章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。
第10章:ラテンアメリカ:タイプ別、用途別、国別、セグメント別の売上高と収益。
第11章:中東・アフリカ:タイプ別、用途別、国別、セグメント別の売上高、収益
第12章:産業チェーン、販売チャネル、主要原材料、流通業者、顧客の分析。
第13章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第14章:調査結果と結論。


ページTOPに戻る


目次

1 Study Coverage
1.1 Quetiapine Fumarate Product Introduction
1.2 Market by Type
1.2.1 Global Quetiapine Fumarate Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Immediate Release Tablets
1.2.3 Extended Release Tablets
1.3 Market by Application
1.3.1 Global Quetiapine Fumarate Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Adult
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Quetiapine Fumarate Market Size Estimates and Forecasts
2.1.1 Global Quetiapine Fumarate Revenue 2020-2031
2.1.2 Global Quetiapine Fumarate Sales 2020-2031
2.2 Quetiapine Fumarate Market Size by Region: 2024 Versus 2031
2.3 Quetiapine Fumarate Sales by Region (2020-2031)
2.3.1 Global Quetiapine Fumarate Sales by Region: 2020-2025
2.3.2 Global Quetiapine Fumarate Sales Forecast by Region (2026-2031)
2.3.3 Global Quetiapine Fumarate Sales Market Share by Region (2020-2031)
2.4 Quetiapine Fumarate Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Quetiapine Fumarate Revenue by Region: 2020-2025
2.4.2 Global Quetiapine Fumarate Revenue Forecast by Region (2026-2031)
2.4.3 Global Quetiapine Fumarate Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Quetiapine Fumarate Sales by Type (2020-2031)
3.1.1.1 Global Quetiapine Fumarate Sales Volume by Type (2020-2031)
3.1.1.2 Global Quetiapine Fumarate Sales Market Share by Type (2020-2031)
3.1.2 Global Quetiapine Fumarate Revenue by Type (2020-2031)
3.1.2.1 Global Quetiapine Fumarate Revenue by Type (2020-2031)
3.1.2.2 Global Quetiapine Fumarate Revenue Market Share by Type (2020-2031)
3.1.3 Quetiapine Fumarate Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Quetiapine Fumarate Sales by Application (2020-2031)
3.2.1.1 Global Quetiapine Fumarate Sales Volume by Application (2020-2031)
3.2.1.2 Global Quetiapine Fumarate Sales Market Share by Application (2020-2031)
3.2.2 Global Quetiapine Fumarate Revenue by Application (2020-2031)
3.2.2.1 Global Quetiapine Fumarate Revenue by Application (2020-2031)
3.2.2.2 Global Quetiapine Fumarate Revenue Market Share by Application (2020-2031)
3.2.3 Quetiapine Fumarate Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Immediate Release Tablets of Quetiapine Fumarate Revenue Market Share by Application
3.3.2 Extended Release Tablets of Quetiapine Fumarate Revenue Market Share by Application
4 Global Quetiapine Fumarate by Manufacturers
4.1 Global Top Quetiapine Fumarate Manufacturers by Sales (2020-2025)
4.1.1 Global Quetiapine Fumarate Sales by Manufacturer (2020-2025)
4.1.2 Global Quetiapine Fumarate Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Quetiapine Fumarate Manufacturers by Revenue (2020-2025)
4.2.1 Global Quetiapine Fumarate Revenue by Manufacturer (2020-2025)
4.2.2 Global Quetiapine Fumarate Revenue Share by Manufacturer (2020-2025)
4.3 Global Quetiapine Fumarate Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Quetiapine Fumarate Manufacturers Covered: Ranking by Revenue
4.4.2 Global Quetiapine Fumarate Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Quetiapine Fumarate Manufacturing Base Distribution, Product Type
4.5.1 Quetiapine Fumarate Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Quetiapine Fumarate Market
4.5.3 Manufacturers Quetiapine Fumarate Product Type and Application
4.5.4 Immediate Release Tablets Market Sales of Quetiapine Fumarate by Manufacturer
4.5.5 Extended Release Tablets Market Sales of Quetiapine Fumarate by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 AstraZeneca
5.1.1 AstraZeneca Company Information
5.1.2 AstraZeneca Description, Business Overview
5.1.3 AstraZeneca Quetiapine Fumarate Products Offered
5.1.4 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.1.5 AstraZeneca Quetiapine Fumarate Sales by Product in 2024
5.1.6 AstraZeneca Quetiapine Fumarate Sales by Application in 2024
5.1.7 AstraZeneca Quetiapine Fumarate Sales by Geographic Area in 2024
5.1.8 AstraZeneca Recent Developments
5.2 Intas
5.2.1 Intas Company Information
5.2.2 Intas Description, Business Overview
5.2.3 Intas Quetiapine Fumarate Products Offered
5.2.4 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Intas Quetiapine Fumarate Sales by Product in 2024
5.2.6 Intas Quetiapine Fumarate Sales by Application in 2024
5.2.7 Intas Quetiapine Fumarate Sales by Geographic Area in 2024
5.2.8 Intas Recent Developments
5.3 TAPI
5.3.1 TAPI Company Information
5.3.2 TAPI Description, Business Overview
5.3.3 TAPI Quetiapine Fumarate Products Offered
5.3.4 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.3.5 TAPI Quetiapine Fumarate Sales by Product in 2024
5.3.6 TAPI Quetiapine Fumarate Sales by Application in 2024
5.3.7 TAPI Quetiapine Fumarate Sales by Geographic Area in 2024
5.3.8 TAPI Recent Developments
5.4 Accord
5.4.1 Accord Company Information
5.4.2 Accord Description, Business Overview
5.4.3 Accord Quetiapine Fumarate Products Offered
5.4.4 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Accord Quetiapine Fumarate Sales by Product in 2024
5.4.6 Accord Quetiapine Fumarate Sales by Application in 2024
5.4.7 Accord Quetiapine Fumarate Sales by Geographic Area in 2024
5.4.8 Accord Recent Developments
5.5 Hexal
5.5.1 Hexal Company Information
5.5.2 Hexal Description, Business Overview
5.5.3 Hexal Quetiapine Fumarate Products Offered
5.5.4 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Hexal Quetiapine Fumarate Sales by Product in 2024
5.5.6 Hexal Quetiapine Fumarate Sales by Application in 2024
5.5.7 Hexal Quetiapine Fumarate Sales by Geographic Area in 2024
5.5.8 Hexal Recent Developments
5.6 Dr.Reddy's
5.6.1 Dr.Reddy's Company Information
5.6.2 Dr.Reddy's Description, Business Overview
5.6.3 Dr.Reddy's Quetiapine Fumarate Products Offered
5.6.4 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Dr.Reddy's Quetiapine Fumarate Sales by Product in 2024
5.6.6 Dr.Reddy's Quetiapine Fumarate Sales by Application in 2024
5.6.7 Dr.Reddy's Quetiapine Fumarate Sales by Geographic Area in 2024
5.6.8 Dr.Reddy's Recent Developments
5.7 Lupin
5.7.1 Lupin Company Information
5.7.2 Lupin Description, Business Overview
5.7.3 Lupin Quetiapine Fumarate Products Offered
5.7.4 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Lupin Quetiapine Fumarate Sales by Product in 2024
5.7.6 Lupin Quetiapine Fumarate Sales by Application in 2024
5.7.7 Lupin Quetiapine Fumarate Sales by Geographic Area in 2024
5.7.8 Lupin Recent Developments
5.8 Sun Pharmaceutical
5.8.1 Sun Pharmaceutical Company Information
5.8.2 Sun Pharmaceutical Description, Business Overview
5.8.3 Sun Pharmaceutical Quetiapine Fumarate Products Offered
5.8.4 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Sun Pharmaceutical Quetiapine Fumarate Sales by Product in 2024
5.8.6 Sun Pharmaceutical Quetiapine Fumarate Sales by Application in 2024
5.8.7 Sun Pharmaceutical Quetiapine Fumarate Sales by Geographic Area in 2024
5.8.8 Sun Pharmaceutical Recent Developments
5.9 Hunan Dongting Pharm
5.9.1 Hunan Dongting Pharm Company Information
5.9.2 Hunan Dongting Pharm Description, Business Overview
5.9.3 Hunan Dongting Pharm Quetiapine Fumarate Products Offered
5.9.4 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Hunan Dongting Pharm Quetiapine Fumarate Sales by Product in 2024
5.9.6 Hunan Dongting Pharm Quetiapine Fumarate Sales by Application in 2024
5.9.7 Hunan Dongting Pharm Quetiapine Fumarate Sales by Geographic Area in 2024
5.9.8 Hunan Dongting Pharm Recent Developments
5.10 SuZhou NO.4 Phamaceutical Factory
5.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
5.10.2 SuZhou NO.4 Phamaceutical Factory Description, Business Overview
5.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Products Offered
5.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.10.5 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales by Product in 2024
5.10.6 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales by Application in 2024
5.10.7 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales by Geographic Area in 2024
5.10.8 SuZhou NO.4 Phamaceutical Factory Recent Developments
5.11 Fuan Pharmaceutical
5.11.1 Fuan Pharmaceutical Company Information
5.11.2 Fuan Pharmaceutical Description, Business Overview
5.11.3 Fuan Pharmaceutical Quetiapine Fumarate Products Offered
5.11.4 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Fuan Pharmaceutical Quetiapine Fumarate Sales by Product in 2024
5.11.6 Fuan Pharmaceutical Quetiapine Fumarate Sales by Application in 2024
5.11.7 Fuan Pharmaceutical Quetiapine Fumarate Sales by Geographic Area in 2024
5.11.8 Fuan Pharmaceutical Recent Developments
5.12 Zhejiang Supor Pharmaceuticals
5.12.1 Zhejiang Supor Pharmaceuticals Company Information
5.12.2 Zhejiang Supor Pharmaceuticals Description, Business Overview
5.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Products Offered
5.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales by Product in 2024
5.12.6 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales by Application in 2024
5.12.7 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales by Geographic Area in 2024
5.12.8 Zhejiang Supor Pharmaceuticals Recent Developments
5.13 Zhejiang Huahai Pharmaceutical
5.13.1 Zhejiang Huahai Pharmaceutical Company Information
5.13.2 Zhejiang Huahai Pharmaceutical Description, Business Overview
5.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Products Offered
5.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales by Product in 2024
5.13.6 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales by Application in 2024
5.13.7 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales by Geographic Area in 2024
5.13.8 Zhejiang Huahai Pharmaceutical Recent Developments
6 North America
6.1 North America Quetiapine Fumarate Market Size YoY Growth 2020-2031
6.2 North America Quetiapine Fumarate Market Facts & Figures by Country
6.2.1 North America Quetiapine Fumarate Sales by Country (2020-2031)
6.2.2 North America Quetiapine Fumarate Revenue by Country (2020-2031)
6.3 North America Quetiapine Fumarate Sales by Type (2020-2025)
6.4 North America Quetiapine Fumarate Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Quetiapine Fumarate Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Quetiapine Fumarate Market Facts & Figures by Region
7.2.1 Asia-Pacific Quetiapine Fumarate Sales by Region (2020-2031)
7.2.2 Asia-Pacific Quetiapine Fumarate Revenue by Region (2020-2031)
7.3 Asia-Pacific Quetiapine Fumarate Sales by Type (2020-2025)
7.4 Asia-Pacific Quetiapine Fumarate Sales by Application (2020-2025)
8 Europe
8.1 Europe Quetiapine Fumarate Market Size YoY Growth 2020-2031
8.2 Europe Quetiapine Fumarate Market Facts & Figures by Country
8.2.1 Europe Quetiapine Fumarate Sales by Country (2020-2031)
8.2.2 Europe Quetiapine Fumarate Revenue by Country (2020-2031)
8.3 Europe Quetiapine Fumarate Sales by Type (2020-2025)
8.4 Europe Quetiapine Fumarate Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Quetiapine Fumarate Market Size YoY Growth 2020-2031
9.2 Latin America Quetiapine Fumarate Market Facts & Figures by Country
9.2.1 Latin America Quetiapine Fumarate Sales by Country (2020-2031)
9.2.2 Latin America Quetiapine Fumarate Revenue by Country (2020-2031)
9.3 Latin America Quetiapine Fumarate Sales by Type (2020-2025)
9.4 Latin America Quetiapine Fumarate Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Quetiapine Fumarate Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Quetiapine Fumarate Market Facts & Figures by Country
10.2.1 Middle East and Africa Quetiapine Fumarate Sales by Country (2020-2031)
10.2.2 Middle East and Africa Quetiapine Fumarate Revenue by Country (2020-2031)
10.3 Middle East and Africa Quetiapine Fumarate Sales by Type (2020-2025)
10.4 Middle East and Africa Quetiapine Fumarate Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Quetiapine Fumarate Supply Chain Analysis
11.2 Quetiapine Fumarate Key Raw Materials and Upstream Suppliers
11.3 Quetiapine Fumarate Clients Analysis
11.4 Quetiapine Fumarate Sales Channel and Sales Model Analysis
11.4.1 Quetiapine Fumarate Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Quetiapine Fumarate Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Quetiapine Fumarate Distributors
12 Quetiapine Fumarate Market Dynamics
12.1 Quetiapine Fumarate Industry Trends
12.2 Quetiapine Fumarate Market Drivers
12.3 Quetiapine Fumarate Market Challenges
12.4 Quetiapine Fumarate Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

 

ページTOPに戻る


 

Summary

In 2024, the global market size of Quetiapine Fumarate was estimated to be worth US$ 153 million and is forecast to reach approximately US$ 131 million by 2031 with a CAGR of -2.2% during the forecast period 2025-2031.
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy"s, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Quetiapine Fumarate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quetiapine Fumarate.
The Quetiapine Fumarate market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Quetiapine Fumarate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quetiapine Fumarate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

By Company
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Segment by Type
Immediate Release Tablets
Extended Release Tablets
Segment by Application
Adult
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Quetiapine Fumarate in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Quetiapine Fumarate sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Quetiapine Fumarate Product Introduction
1.2 Market by Type
1.2.1 Global Quetiapine Fumarate Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Immediate Release Tablets
1.2.3 Extended Release Tablets
1.3 Market by Application
1.3.1 Global Quetiapine Fumarate Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Adult
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Quetiapine Fumarate Market Size Estimates and Forecasts
2.1.1 Global Quetiapine Fumarate Revenue 2020-2031
2.1.2 Global Quetiapine Fumarate Sales 2020-2031
2.2 Quetiapine Fumarate Market Size by Region: 2024 Versus 2031
2.3 Quetiapine Fumarate Sales by Region (2020-2031)
2.3.1 Global Quetiapine Fumarate Sales by Region: 2020-2025
2.3.2 Global Quetiapine Fumarate Sales Forecast by Region (2026-2031)
2.3.3 Global Quetiapine Fumarate Sales Market Share by Region (2020-2031)
2.4 Quetiapine Fumarate Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Quetiapine Fumarate Revenue by Region: 2020-2025
2.4.2 Global Quetiapine Fumarate Revenue Forecast by Region (2026-2031)
2.4.3 Global Quetiapine Fumarate Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Quetiapine Fumarate Sales by Type (2020-2031)
3.1.1.1 Global Quetiapine Fumarate Sales Volume by Type (2020-2031)
3.1.1.2 Global Quetiapine Fumarate Sales Market Share by Type (2020-2031)
3.1.2 Global Quetiapine Fumarate Revenue by Type (2020-2031)
3.1.2.1 Global Quetiapine Fumarate Revenue by Type (2020-2031)
3.1.2.2 Global Quetiapine Fumarate Revenue Market Share by Type (2020-2031)
3.1.3 Quetiapine Fumarate Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Quetiapine Fumarate Sales by Application (2020-2031)
3.2.1.1 Global Quetiapine Fumarate Sales Volume by Application (2020-2031)
3.2.1.2 Global Quetiapine Fumarate Sales Market Share by Application (2020-2031)
3.2.2 Global Quetiapine Fumarate Revenue by Application (2020-2031)
3.2.2.1 Global Quetiapine Fumarate Revenue by Application (2020-2031)
3.2.2.2 Global Quetiapine Fumarate Revenue Market Share by Application (2020-2031)
3.2.3 Quetiapine Fumarate Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Immediate Release Tablets of Quetiapine Fumarate Revenue Market Share by Application
3.3.2 Extended Release Tablets of Quetiapine Fumarate Revenue Market Share by Application
4 Global Quetiapine Fumarate by Manufacturers
4.1 Global Top Quetiapine Fumarate Manufacturers by Sales (2020-2025)
4.1.1 Global Quetiapine Fumarate Sales by Manufacturer (2020-2025)
4.1.2 Global Quetiapine Fumarate Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Quetiapine Fumarate Manufacturers by Revenue (2020-2025)
4.2.1 Global Quetiapine Fumarate Revenue by Manufacturer (2020-2025)
4.2.2 Global Quetiapine Fumarate Revenue Share by Manufacturer (2020-2025)
4.3 Global Quetiapine Fumarate Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Quetiapine Fumarate Manufacturers Covered: Ranking by Revenue
4.4.2 Global Quetiapine Fumarate Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Quetiapine Fumarate Manufacturing Base Distribution, Product Type
4.5.1 Quetiapine Fumarate Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Quetiapine Fumarate Market
4.5.3 Manufacturers Quetiapine Fumarate Product Type and Application
4.5.4 Immediate Release Tablets Market Sales of Quetiapine Fumarate by Manufacturer
4.5.5 Extended Release Tablets Market Sales of Quetiapine Fumarate by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 AstraZeneca
5.1.1 AstraZeneca Company Information
5.1.2 AstraZeneca Description, Business Overview
5.1.3 AstraZeneca Quetiapine Fumarate Products Offered
5.1.4 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.1.5 AstraZeneca Quetiapine Fumarate Sales by Product in 2024
5.1.6 AstraZeneca Quetiapine Fumarate Sales by Application in 2024
5.1.7 AstraZeneca Quetiapine Fumarate Sales by Geographic Area in 2024
5.1.8 AstraZeneca Recent Developments
5.2 Intas
5.2.1 Intas Company Information
5.2.2 Intas Description, Business Overview
5.2.3 Intas Quetiapine Fumarate Products Offered
5.2.4 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Intas Quetiapine Fumarate Sales by Product in 2024
5.2.6 Intas Quetiapine Fumarate Sales by Application in 2024
5.2.7 Intas Quetiapine Fumarate Sales by Geographic Area in 2024
5.2.8 Intas Recent Developments
5.3 TAPI
5.3.1 TAPI Company Information
5.3.2 TAPI Description, Business Overview
5.3.3 TAPI Quetiapine Fumarate Products Offered
5.3.4 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.3.5 TAPI Quetiapine Fumarate Sales by Product in 2024
5.3.6 TAPI Quetiapine Fumarate Sales by Application in 2024
5.3.7 TAPI Quetiapine Fumarate Sales by Geographic Area in 2024
5.3.8 TAPI Recent Developments
5.4 Accord
5.4.1 Accord Company Information
5.4.2 Accord Description, Business Overview
5.4.3 Accord Quetiapine Fumarate Products Offered
5.4.4 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Accord Quetiapine Fumarate Sales by Product in 2024
5.4.6 Accord Quetiapine Fumarate Sales by Application in 2024
5.4.7 Accord Quetiapine Fumarate Sales by Geographic Area in 2024
5.4.8 Accord Recent Developments
5.5 Hexal
5.5.1 Hexal Company Information
5.5.2 Hexal Description, Business Overview
5.5.3 Hexal Quetiapine Fumarate Products Offered
5.5.4 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Hexal Quetiapine Fumarate Sales by Product in 2024
5.5.6 Hexal Quetiapine Fumarate Sales by Application in 2024
5.5.7 Hexal Quetiapine Fumarate Sales by Geographic Area in 2024
5.5.8 Hexal Recent Developments
5.6 Dr.Reddy's
5.6.1 Dr.Reddy's Company Information
5.6.2 Dr.Reddy's Description, Business Overview
5.6.3 Dr.Reddy's Quetiapine Fumarate Products Offered
5.6.4 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Dr.Reddy's Quetiapine Fumarate Sales by Product in 2024
5.6.6 Dr.Reddy's Quetiapine Fumarate Sales by Application in 2024
5.6.7 Dr.Reddy's Quetiapine Fumarate Sales by Geographic Area in 2024
5.6.8 Dr.Reddy's Recent Developments
5.7 Lupin
5.7.1 Lupin Company Information
5.7.2 Lupin Description, Business Overview
5.7.3 Lupin Quetiapine Fumarate Products Offered
5.7.4 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Lupin Quetiapine Fumarate Sales by Product in 2024
5.7.6 Lupin Quetiapine Fumarate Sales by Application in 2024
5.7.7 Lupin Quetiapine Fumarate Sales by Geographic Area in 2024
5.7.8 Lupin Recent Developments
5.8 Sun Pharmaceutical
5.8.1 Sun Pharmaceutical Company Information
5.8.2 Sun Pharmaceutical Description, Business Overview
5.8.3 Sun Pharmaceutical Quetiapine Fumarate Products Offered
5.8.4 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Sun Pharmaceutical Quetiapine Fumarate Sales by Product in 2024
5.8.6 Sun Pharmaceutical Quetiapine Fumarate Sales by Application in 2024
5.8.7 Sun Pharmaceutical Quetiapine Fumarate Sales by Geographic Area in 2024
5.8.8 Sun Pharmaceutical Recent Developments
5.9 Hunan Dongting Pharm
5.9.1 Hunan Dongting Pharm Company Information
5.9.2 Hunan Dongting Pharm Description, Business Overview
5.9.3 Hunan Dongting Pharm Quetiapine Fumarate Products Offered
5.9.4 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Hunan Dongting Pharm Quetiapine Fumarate Sales by Product in 2024
5.9.6 Hunan Dongting Pharm Quetiapine Fumarate Sales by Application in 2024
5.9.7 Hunan Dongting Pharm Quetiapine Fumarate Sales by Geographic Area in 2024
5.9.8 Hunan Dongting Pharm Recent Developments
5.10 SuZhou NO.4 Phamaceutical Factory
5.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
5.10.2 SuZhou NO.4 Phamaceutical Factory Description, Business Overview
5.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Products Offered
5.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.10.5 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales by Product in 2024
5.10.6 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales by Application in 2024
5.10.7 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales by Geographic Area in 2024
5.10.8 SuZhou NO.4 Phamaceutical Factory Recent Developments
5.11 Fuan Pharmaceutical
5.11.1 Fuan Pharmaceutical Company Information
5.11.2 Fuan Pharmaceutical Description, Business Overview
5.11.3 Fuan Pharmaceutical Quetiapine Fumarate Products Offered
5.11.4 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Fuan Pharmaceutical Quetiapine Fumarate Sales by Product in 2024
5.11.6 Fuan Pharmaceutical Quetiapine Fumarate Sales by Application in 2024
5.11.7 Fuan Pharmaceutical Quetiapine Fumarate Sales by Geographic Area in 2024
5.11.8 Fuan Pharmaceutical Recent Developments
5.12 Zhejiang Supor Pharmaceuticals
5.12.1 Zhejiang Supor Pharmaceuticals Company Information
5.12.2 Zhejiang Supor Pharmaceuticals Description, Business Overview
5.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Products Offered
5.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales by Product in 2024
5.12.6 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales by Application in 2024
5.12.7 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales by Geographic Area in 2024
5.12.8 Zhejiang Supor Pharmaceuticals Recent Developments
5.13 Zhejiang Huahai Pharmaceutical
5.13.1 Zhejiang Huahai Pharmaceutical Company Information
5.13.2 Zhejiang Huahai Pharmaceutical Description, Business Overview
5.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Products Offered
5.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales by Product in 2024
5.13.6 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales by Application in 2024
5.13.7 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales by Geographic Area in 2024
5.13.8 Zhejiang Huahai Pharmaceutical Recent Developments
6 North America
6.1 North America Quetiapine Fumarate Market Size YoY Growth 2020-2031
6.2 North America Quetiapine Fumarate Market Facts & Figures by Country
6.2.1 North America Quetiapine Fumarate Sales by Country (2020-2031)
6.2.2 North America Quetiapine Fumarate Revenue by Country (2020-2031)
6.3 North America Quetiapine Fumarate Sales by Type (2020-2025)
6.4 North America Quetiapine Fumarate Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Quetiapine Fumarate Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Quetiapine Fumarate Market Facts & Figures by Region
7.2.1 Asia-Pacific Quetiapine Fumarate Sales by Region (2020-2031)
7.2.2 Asia-Pacific Quetiapine Fumarate Revenue by Region (2020-2031)
7.3 Asia-Pacific Quetiapine Fumarate Sales by Type (2020-2025)
7.4 Asia-Pacific Quetiapine Fumarate Sales by Application (2020-2025)
8 Europe
8.1 Europe Quetiapine Fumarate Market Size YoY Growth 2020-2031
8.2 Europe Quetiapine Fumarate Market Facts & Figures by Country
8.2.1 Europe Quetiapine Fumarate Sales by Country (2020-2031)
8.2.2 Europe Quetiapine Fumarate Revenue by Country (2020-2031)
8.3 Europe Quetiapine Fumarate Sales by Type (2020-2025)
8.4 Europe Quetiapine Fumarate Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Quetiapine Fumarate Market Size YoY Growth 2020-2031
9.2 Latin America Quetiapine Fumarate Market Facts & Figures by Country
9.2.1 Latin America Quetiapine Fumarate Sales by Country (2020-2031)
9.2.2 Latin America Quetiapine Fumarate Revenue by Country (2020-2031)
9.3 Latin America Quetiapine Fumarate Sales by Type (2020-2025)
9.4 Latin America Quetiapine Fumarate Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Quetiapine Fumarate Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Quetiapine Fumarate Market Facts & Figures by Country
10.2.1 Middle East and Africa Quetiapine Fumarate Sales by Country (2020-2031)
10.2.2 Middle East and Africa Quetiapine Fumarate Revenue by Country (2020-2031)
10.3 Middle East and Africa Quetiapine Fumarate Sales by Type (2020-2025)
10.4 Middle East and Africa Quetiapine Fumarate Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Quetiapine Fumarate Supply Chain Analysis
11.2 Quetiapine Fumarate Key Raw Materials and Upstream Suppliers
11.3 Quetiapine Fumarate Clients Analysis
11.4 Quetiapine Fumarate Sales Channel and Sales Model Analysis
11.4.1 Quetiapine Fumarate Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Quetiapine Fumarate Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Quetiapine Fumarate Distributors
12 Quetiapine Fumarate Market Dynamics
12.1 Quetiapine Fumarate Industry Trends
12.2 Quetiapine Fumarate Market Drivers
12.3 Quetiapine Fumarate Market Challenges
12.4 Quetiapine Fumarate Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(channel)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/04/15 10:26

144.64 円

164.16 円

193.23 円

ページTOPに戻る